Alpha Teknova (TKNO) Invested Capital (2023 - 2024)

Alpha Teknova (TKNO) posted quarterly Invested Capital of $4.0 million for Q4 2024, up 60.01% quarter-over-quarter from $2.5 million in Q3 2024.

Alpha Teknova (TKNO) Invested Capital (2023 - 2024) Analysis & Trends

Alpha Teknova (TKNO) has reported Invested Capital for 2 consecutive years, with $4.0 million the latest figure, recorded in Q4 2024.

In Q4 2024, Invested Capital changed N/A year-over-year to $4.0 million; the TTM figure through Sep 2025 stood at $4.0 million (up 14.3% YoY), while the FY2024 annual figure was $4.0 million, changed N/A from the prior year.
Invested Capital climbed to $4.0 million in Q4 2024 per TKNO's latest filing, from $2.5 million in the prior quarter.
Across five years, Invested Capital topped out at $22.2 million in Q2 2023 and bottomed at $1.0 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	9.90 Bn
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	4.50 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	3.74 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	-
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	1.74 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	-
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	73.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	630.00 Mn
10	Alpha Teknova	374.37 Mn	356.94 Mn	4.89 Mn	-

Download Data